Alexander Belser
Chief Tech/Sci/R&D Officer chez CYBIN INC.
Profil
Alexander Belser is currently the Chief Clinical Officer at Cybin, Inc. He previously worked as the Chief Clinical Officer at Adelia Therapeutics, Inc. Belser has a graduate degree from the University of Cambridge, a doctorate from New York University, and an undergraduate degree from Georgetown University.
Postes actifs de Alexander Belser
| Sociétés | Poste | Début |
|---|---|---|
| CYBIN INC. | Chief Tech/Sci/R&D Officer | 01/10/2020 |
Anciens postes connus de Alexander Belser
| Sociétés | Poste | Fin |
|---|---|---|
Adelia Therapeutics, Inc.
 Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | Chief Tech/Sci/R&D Officer | - |
Formation de Alexander Belser
| University of Cambridge | Graduate Degree |
| New York University | Doctorate Degree |
| Georgetown University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CYBIN INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | Health Technology |
